期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 64, 期 -, 页码 -出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2022.128683
关键词
Photoinduced drug release; Photocaged B-Raf V600E inhibitor; Melanoma; Precise treatment
资金
- National Natural Science Foundation of China [22037003, 81820108029, 81874284]
- State Key Laboratory of Bioorganic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry
Photoinduced drug release is a promising strategy for precise cancer therapy. The newly designed photocaged B-RafV600E inhibitor 2 can release active drugs under UV irradiation, effectively inhibiting the proliferation of melanoma cells and showing similar effects under sunlight exposure.
Photoinduced drug release can reduce systemic side effects by releasing active drugs with high spatiotemporal accuracy, representing a promising strategy for precise cancer therapy. Here we designed and synthesized a novel photocaged B-RafV600E inhibitor 2, which, upon UV irradiation, could release a potent B-Raf(V600E) inhibitor 1. Accordingly, once activated by the UV light, compound 2 could potently inhibit the proliferation of melanoma cells bearing B-Raf(V600E) mutant while sparing melanoma cells expressing wild-type B-Raf, and could dose dependently suppress the activation of the MAPK signaling pathway. Notably, the UV-mediated active component release and the resulting antiproliferative effects of compound 2 could be recapitulated when exposed to the sunlight, greatly enhancing its practicality. This photocaged B-RafV600E inhibitor 2 might serve as a novel therapeutic agent toward precise melanoma treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据